Dyne Therapeutics
196 hedge funds and large institutions have $1.23B invested in Dyne Therapeutics in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 95 increasing their positions, 52 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
196
Holders Change
-8
Holders Change %
-3.92%
% of All Funds
2.63%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.08%
New
23
Increased
95
Reduced
52
Closed
30
Calls
$390K
Puts
$823K
Net Calls
-$433K
Net Calls Change
-$3.1M
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$30.4M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$20.2M |
| 3 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$13.9M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$13.8M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$13.3M |
Top Sellers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$20.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$19.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.4M |
| 4 |
VPC
Vestal Point Capital
New York
|
-$10.2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$8.72M |
